No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials

DEGRO practical guideline for partial-breast irradiation

(2020) V. Strnad et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival

(2020) Jayant S. Vaidya et al.   JAMA Oncology

A Retrospective Dosimetric Study of Radiotherapy Patients with Left-Sided Breast Cancer; Patient Selection Criteria for Deep Inspiration Breath Hold Technique

(2019) Mikaela Dell’Oro et al.   Cancers

Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases

(2019) Stefanie Corradini et al.   Cancers

Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial

(2019) Indrani S. Bhattacharya et al.   RADIOTHERAPY AND ONCOLOGY

Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial

(2019) Indrani S. Bhattacharya et al.   RADIOTHERAPY AND ONCOLOGY

Heart-sparing radiotherapy techniques in breast cancer patients: a recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO)

(2019) Marciana-Nona Duma et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial

(2019) J.R. White et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

(2019) Timothy J Whelan et al.   LANCET

Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

(2019) Frank A Vicini et al.   LANCET

The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation

(2018) Chirag Shah et al.   Brachytherapy

Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer

(2018) Julia Kaiser et al.   Breast Care

A Randomized Comparison of Radiation Therapy Techniques in the Management of Node-Positive Breast Cancer: Primary Outcomes Analysis

(2018) Reshma Jagsi et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial

(2018) Rebekka Schäfer et al.   LANCET ONCOLOGY

Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial

(2018) Tammy Corica et al.   Radiation Oncology

ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost – GEC-ESTRO Breast Cancer Working Group practical recommendations

(2018) Vratislav Strnad et al.   RADIOTHERAPY AND ONCOLOGY

Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects

(2018) et al.   Cancers

Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial

(2018) Indrani S. Bhattacharya et al.   JOURNAL OF CLINICAL ONCOLOGY

Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial

(2017) Icro Meattini et al.   EUROPEAN JOURNAL OF CANCER

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

(2017) Carolyn Taylor et al.   JOURNAL OF CLINICAL ONCOLOGY

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

(2017) Charlotte E Coles et al.   LANCET

Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial

(2017) Csaba Polgár et al.   LANCET ONCOLOGY

SP-0315: Partial breast radiotherapy after breast conservation for breast cancer: early results from the randomised DBCG PBI trial

(2017) B. Offersen et al.   RADIOTHERAPY AND ONCOLOGY

Reduced Mortality With Partial-Breast Irradiation for Early Breast Cancer: A Meta-Analysis of Randomized Trials

(2016) Jayant S. Vaidya et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Cosmesis and Breast-Related Quality of Life Outcomes After Intraoperative Radiation Therapy for Early Breast Cancer: A Substudy of the TARGIT-A Trial

(2016) Tammy Corica et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial

(2016) Vratislav Strnad et al.   LANCET

Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model

(2015) Suhail A.R. Doi et al.   Contemporary Clinical Trials

Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial

(2015) Lorenzo Livi et al.   EUROPEAN JOURNAL OF CANCER

Predictors of Adverse Cosmetic Outcome in the RAPID Trial: An Exploratory Analysis

(2015) David Peterson et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Recommendations from GEC ESTRO Breast Cancer Working Group (I): Target definition and target delineation for accelerated or boost Partial Breast Irradiation using multicatheter interstitial brachytherapy after breast conserving closed cavity surgery

(2015) Vratislav Strnad et al.   RADIOTHERAPY AND ONCOLOGY

Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial

(2013) Mohammed R. S. Keshtgar et al.   BREAST CANCER RESEARCH AND TREATMENT

Interim Cosmetic and Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation Using Three-Dimensional Conformal External Beam Radiation Therapy

(2013) Ivo A. Olivotto et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

(2013) Jayant S Vaidya et al.   LANCET

Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial

(2013) Umberto Veronesi et al.   LANCET ONCOLOGY

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials

(2013) Joanne S Haviland et al.   LANCET ONCOLOGY

Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer

(2013) Sarah C. Darby et al.   NEW ENGLAND JOURNAL OF MEDICINE

Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A

(2013) Grit Welzel et al.   Radiation Oncology

Breast-conserving therapy with partial or whole breast irradiation: Ten-year results of the Budapest randomized trial

(2013) Csaba Polgár et al.   RADIOTHERAPY AND ONCOLOGY

Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A

(2012) Elena Sperk et al.   BREAST CANCER RESEARCH AND TREATMENT

Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomized trial

(2011) Kenneth Geving Andersen et al.   BREAST

Ipsilateral Breast Tumor Relapse: Local Recurrence Versus New Primary Tumor and the Effect of Whole-Breast Radiotherapy on the Rate of New Primaries

(2010) Dorothy M. Gujral et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial

(2010) Jayant S Vaidya et al.   LANCET

Do All Patients Require Radiotherapy after Breast-Conserving Surgery?

(2010) Anita R. Skandarajah et al.   Cancers

Accelerated Partial Breast Irradiation With IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial

(2009) Lorenzo Livi et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS